Genetics - Cellular basis

British Medical Bulletin

Volumn 64, Issue , 2002, Pages 45-58

  Buda, Andrea ^a   Pignatelli, Massimo ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; UVOMORULIN; WNT PROTEIN;

CANCER GENETICS; CELL ADHESION; CELL DIFFERENTIATION; CELL MUTANT; CELL SURFACE; CELL SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; EPITHELIUM CELL; GROWTH REGULATION; HUMAN; INTESTINE MUCOSA; PRIORITY JOURNAL; PROCESS MODEL; REGULATORY MECHANISM; REVIEW; SOMATIC CELL GENETICS;

ANIMALS; BETA CATENIN; CADHERINS; CELL ADHESION; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; GENES, APC; HUMANS; INTESTINAL MUCOSA; MUTATION; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0036031769     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/64.1.45     Document Type: Review

References (69)

1. Kinzler KW, Vogelstein B. The colorectal cancer gene hunt: Current findings. Hosp Pract 1992; 27: 51-8
2. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-70
3. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997; 386: 761, 763
4. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-7
5. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58: 1130-4
6. Morin PJ. Beta-catenin signaling and cancer. Bioessays 1999; 21: 1021-30
7. McCrea PD, Brieher WM, Gumbiner BM. Induction of a secondary body axis in Xenopus by antibodies to beta-catenin. J Cell Biol 1993; 123: 477-84
8. Yost C, Torres M, Miller JR, Huang E, Kimelman D, Moon RT. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 1996; 10: 1443-54
9. Liu C, Kato Y, Zhang Z, Do VM, Yankner BA, He X. Beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci USA 1999; 96: 6273-8
10. Hao X, Tomlinson I, Ilyas M, Palazzo JP, Talbot IC. Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours. Virchows Arch 1997; 431: 167-72
11. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 1998; 194: 701-4
12. Hugh TJ, Dillon SA, O'Dowd G et al. Beta-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 1999; 82: 504-11
13. Maruyama K, Ochiai A, Akimoto S et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 2000; 59: 302-9
14. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 1997; 94: 10330-4
15. Abraham SC, Wu TT, Klimstra DS et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: Frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol 2001; 159: 1619-27
16. Sekine S, Shibata T, Yamauchi Y et al. Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch 2002; 440: 381-6
17. Samowitz WS, Powers MD, Spirio LN, Nollet F, van Roy F, Slattery ML. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 1999; 59: 1442-4
18. Wada M, Miller CW, Yokota J, Lee E, Mizoguchi H, Koeffler HP. Molecular analysis of the adenomatous polyposis coli gene in sarcomas, hematological malignancies and non-colonic, neoplastic tissues. J Mol Med 1997; 75: 139-44
19. Aust DE, Terdiman JP, Willenbucher RF et al. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers. Mod Pathol 2001; 14: 29-39
20. Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B, Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994; 54: 3676-81
21. Zumbrunn J, Kinoshita K, Hyman AA, Nathke IS. Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3 beta phosphorylation. Curr Biol 2001; 11: 44-9
22. Mimori-Kiyosue Y, Tsukita S. Where is APC going? J Cell Biol 2001; 154: 1105-9
23. Mimori-Kiyosue Y, Shiina N, Tsukita S. Adenomatous polyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells. J Cell Biol 2000; 148: 505-18
24. Kawasaki Y, Senda T, Ishidate T et al. Asef, a link between the tumor suppressor APC and G-protein signaling. Science 2000; 289: 1194-7
25. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5
26. Wijnhoven BP, Pignatelli M. E-cadherin-catenin: More than a 'sticky' molecular complex. Lancet 1999; 354: 356-7
27. Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-19
28. Pignatelli M, Liu D, Nasim MM, Stamp GW, Hirano S, Takeichi M. Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells. Br J Cancer 1992; 66: 629-34
29. Kinsella AR, Lepts GC, Hill CL, Jones M. Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis 1994; 12: 335-42
30. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-3
31. Becker KF, Atkinson MJ, Reich U et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-52
32. Wheeler JM, Kim HC, Efstathiou JA, Ilyas M, Mortensen NJ, Bodmer WF. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 2001; 48: 367-71
33. St Croix B, Sheehan C, Rak JW et al. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27 (KIP1). J Cell Biol 1998; 142: 557-71
34. Brabletz T, Jung A, Reu S et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001; 98: 10356-61
35. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987-91
36. Gofuku J, Shiozaki H, Tsujinaka T et al. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Am J Clin Pathol 1999; 111: 29-37
37. Efstathiou JA, Noda M, Rowan A et al. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci USA 1998; 95: 3122-7
38. Kinch MS, Clark GJ, Der CJ, Burridge K. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol 1995; 130: 461-71
39. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51
40. Boutros M, Mihaly J, Bouwmeester T, Mlodzik M. Signaling specificity by Frizzled receptors in Drosophila. Science 2000; 288: 1825-8
41. Smalley MJ, Sara E, Paterson H et al. Interaction of axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. EMBO J 1999; 18: 2823-35
42. -/- colon carcinoma. Science 1997; 275: 1784-7
43. Korinek V, Barker N, Moerer P et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998; 19: 379-83
44. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-20
45. Satoh S, Daigo Y, Furukawa Y et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24: 245-50
46. Liu W, Dong X, Mai M et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 2000; 26: 146-7
47. Shimizu Y, Ikeda S, Fujimori M et al. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 2002; 33: 73-81
48. Mann B, Gelos M, Siedow A et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999; 96: 1603-8
49. Newell KJ, Witty JP, Rodgers WH, Matrisian LM. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 1994; 10: 199-206
50. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 1997; 94: 1402-7
51. Reuning U, Magdolen V, Wilhelm O et al. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis [review]. Int J Oncol 1998; 13: 893-906
52. Buo L, Meling GI, Karlsrud TS, Johansen HT, Aasen AO. Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness. Hum Pathol 1995; 26: 1133-8
53. Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 2001; 61: 6050-4
54. Lickert H, Domon C, Huls G et al. Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development 2000; 127: 3805-13
55. Domon-Dell C, Freund JN. Stimulation of Cdx1 by oncogenic beta-catenin/Tcf4 in colon cancer cells; opposite effect of the CDX2 homeoprotein. FEBS Lett 2002; 518: 83-7
56. Butler LM, Hewett PJ, Fitridge RA, Cowled PA. Deregulation of apoptosis in colorectal carcinoma: Theoretical and therapeutic implications. Aust NZ J Surg 1999; 69: 88-94
57. Linn SC, Giaccone G. MDR1/P-glycoprotein expression in colorectal cancer. Eur J Cancer 1995; 31A: 1291-4
58. Damalas A, Ben-Ze'ev A, Simcha I et al. Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J 1999; 18: 3054-63
59. Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 2001; 7: 915-26
60. Wang CY, Eshleman JR, Willson JK, Markowitz S. Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res 1995; 55: 5101-5
61. Markowitz S, Wang J, Myeroff L et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336-8
62. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M, Moorghen M. TGF-beta expression in the human colon: Differential immunostaining along crypt epithelium. Br J Cancer 1993; 68: 137-9
63. Manning AM, Williams AC, Game SM, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): Conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene 1991; 6: 1471-6
64. Filmus J, Zhao J, Buick RN. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-beta 1) and alters the number and type of TGF-beta 1 receptors in rat intestinal epithelial cell clones. Oncogene 1992; 7: 521-6
65. Zhang T, Nanney LB, Peeler MO et al. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression. Cancer Res 1997; 57: 1638-43
66. Parsons R, Myeroff LL, Liu B et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995; 55: 5548-50
67. Howe JR, Roth S, Ringold JC et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280: 1086-8
68. Nishita M, Hashimoto MK, Ogata S et al. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 2000; 403: 781-5
69. Letamendia A, Labbe E, Attisano L. Transcriptional regulation by Smads: Crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 2001; 83 (Suppl 1): S31-9